Skip to content
Boost Up Blog – Lifestyle
Author:
Boralex Inc.
Ensysce Biosciences to Showcase “A New Era in Pain Therapeutics” at PAINWeek 2026 Symposium
August 21, 2026
Boralex Receives all Regulatory Approvals for Arrangement with Brookfield and La Caisse
August 6, 2026
Boralex announces €1.45 billion single platform-level financing in France to support its portfolio of operating assets and development projects
June 30, 2026
Boralex Obtains Final Court Approval of the Arrangement with Brookfield and La Caisse
June 5, 2026
Boralex Announces Shareholder Approval of the Arrangement with Brookfield and La Caisse
June 4, 2026
Both Leading Independent Proxy Advisors Recommend Boralex Shareholders Vote FOR Arrangement
May 22, 2026
Boralex and Six Nations of the Grand River Development Corporation announce the closing of a $202 million financing
April 2, 2026
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
March 31, 2026
Boralex Enters into Definitive Agreement to be Acquired by Brookfield, alongside La Caisse, Supporting its Next Phase of Growth as a Standalone Private Company
March 25, 2026
Boralex Responds to Recent Statements in the Media
March 23, 2026